A citation-based method for searching scientific literature

U Lopatin, X Yao, R K Williams, J J Bleesing, J K Dale, D Wong, J Teruya-Feldstein, S Fritz, M R Morrow, I Fuss, M C Sneller, M Raffeld, T A Fleisher, J M Puck, W Strober, E S Jaffe, S E Straus. Blood 2001
Times Cited: 74

N A Avila, A J Dwyer, J K Dale, U A Lopatin, M C Sneller, E S Jaffe, J M Puck, S E Straus. Radiology 1999
Times Cited: 19

List of shared articles

Times cited

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).
Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, Kenneth Steadman, Alan T Remaley, Jeffrey I Cohen, Stephen E Straus, V Koneti Rao. Exp Hematol 2009

Causes and consequences of the autoimmune lymphoproliferative syndrome.
V Koneti Rao, Stephen E Straus. Hematology 2006

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Kennichi C Dowdell, Julie E Niemela, Susan Price, Joie Davis, Ronald L Hornung, João Bosco Oliveira, Jennifer M Puck, Elaine S Jaffe, Stefania Pittaluga, Jeffrey I Cohen,[...]. Blood 2010

Autoimmune lymphoproliferative syndrome (ALPS).
Jack J H Bleesing. Curr Pharm Des 2003

Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Kennichi C Dowdell, Janet K Dale, Faith Dugan, Lesley Pesnicak, Lilia L Bi, Victoria Hoffmann, Scott Penzak, Nilo A Avila, Thomas A Fleisher,[...]. Am J Hematol 2007

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003

Cell-death signaling and human disease.
Frédéric Rieux-Laucat, Alain Fischer, Françoise Le Deist. Curr Opin Immunol 2003

Genetic defects of apoptosis and primary immunodeficiency.
Helen C Su, Michael J Lenardo. Immunol Allergy Clin North Am 2008